Private-sector incentive design for essential medicines access

Private suppliers can accelerate medicine access when commercial incentives are aligned with public service outcomes.

In fragmented systems, weak payment predictability and poor demand signaling increase stock risk and reduce supplier participation. Effective incentive design addresses both issues directly.

Advisory priorities for incentive alignment

• Improve payment-cycle reliability and dispute resolution speed.
• Use pooled demand where feasible to reduce price volatility.
• Build performance clauses that reward service reliability, not only unit price.

When these elements are coordinated, systems preserve commercial viability while improving medicine access outcomes.